Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$264,342,129
-$9,773,438 QoQ
Shares Held
1,215,422
+1.3% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 63.17320239390105.ToString("F0")%
Shared 12.729323642323406.ToString("F0")%
None 24.097473963775546.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$1,783,418
PutShares
8,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Cerity Partners LLC holds $2,080,837,635 across 16 Drug Manufacturers - General names. ABBV ranks #3 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
732,549 | $673,776,592 | |
| 2 | JNJ |
Johnson & Johnson
|
1,846,524 | $451,364,326 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,215,422 | $264,342,129 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,639,510 | $197,216,656 | |
| 5 | AMGN |
Amgen Inc
|
433,555 | $152,546,325 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,392,773 | $84,471,681 | |
| 7 | AZN |
Astrazeneca PLC
|
301,215 | $59,405,621 | |
| 8 | NVS |
Novartis AG
|
329,910 | $50,393,751 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,783,418 | 8,200 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $264,342,129 | 1,215,422 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $274,115,567 | 1,199,683 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $263,320,485 | 1,137,257 | Shares | Other | 2025-10-22 | |
| 2025-06-30 | $210,147,084 | 1,132,136 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $205,125,946 | 979,028 | Shares | Other | 2025-04-30 | |
| 2024-12-31 | $155,295,228 | 873,918 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $164,789,950 | 834,464 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $116,655,383 | 680,127 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $128,754,715 | 707,055 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $149,993,913 | 967,890 | Shares | Other | 2024-01-26 | |
| 2023-09-30 | $73,485,685 | 492,994 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $87,489,215 | 649,367 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $87,079,608 | 546,399 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $70,795,523 | 438,064 | Shares | Other | 2023-02-15 | |
| 2022-09-30 | $29,923,193 | 222,958 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $36,315,308 | 237,107 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $44,566,632 | 274,916 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $34,805,111 | 257,054 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $25,363,257 | 235,128 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $25,766,512 | 228,751 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $24,541,698 | 226,776 | Shares | Sole | 2021-08-11 | |
| 2020-12-31 | $12,804,425 | 119,500 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $8,301,692 | 94,779 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,672,079 | 78,143 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $2,991,067 | 39,258 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||